Results

Total Results: 162 records

Showing results for "years".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/StatinTherapyForThePreventionAndTreatmentOfCVDeCQMDerived_Change_Log.txt
    January 01, 2024 - ASCVD or with Familial Hypercholesterolemia - Population 3: highest LDL cholesterol in the past 3 years … ; now unrestricted) - Population 2 Inclusions: Changed age restriction from >= 21 years to >= 20 years … old to 20 - 75 years old - Inclusions: Population 4: New population for patients age 40 to 75 years … ; now unrestricted) - Population 2 Inclusions: Changed age restriction from >= 21 years to >= 20 years … old to 20 - 75 years old - Inclusions: Population 4: New population for patients age 40 to 75 years
  2. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-08/StatinTherapyForThePreventionAndTreatmentOfCVDeCQMDerived_Change_Log_0.txt
    January 01, 2023 - ASCVD or with Familial Hypercholesterolemia - Population 3: highest LDL cholesterol in the past 3 years … 2.16.840.1.113762.1.4.1108.85) - Population 1 Inclusions: Removed age restriction criteria (was >= 21 years … ; now unrestricted) - Population 2 Inclusions: Changed age restriction from >= 21 years to >= 20 years … 2.16.840.1.113762.1.4.1108.85) - Population 1 Inclusions: Removed age restriction criteria (was >= 21 years … ; now unrestricted) - Population 2 Inclusions: Changed age restriction from >= 21 years to >= 20 years
  3. cds.ahrq.gov/sites/default/files/cds/artifact/66551/ASPIRE_GuidanceForOsteoporosisFlow.pdf
    June 08, 2022 - Handout Yes Patient has active Bisphosphonate treatment active Bisphosphonate treatment < 5 years … Yes active Bisphosphonate treatment > 5 years Yes General Info on Fall Risk Handout No No
  4. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
    January 01, 2020 - , and are willing to take low-dose aspirin daily for at least 10 years.2 (Grade B Recommendation) … are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years. … Results older than 6 years may not reflect the patient's current condition as accurately.
  5. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
    April 01, 2021 - are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … Inclusion logic: Patient is >=50 years of age and <= 69 years of age AND the MOST RECENT 10-Year … The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years. … Results older than 6 years may not reflect the patient’s current condition as accurately.
  6. cds.ahrq.gov/sites/default/files/cds/artifact/106/HWI_2017.pptx
    January 01, 2017 - patients with a BMI above the 95th percentile **Appropriate comorbidities screening: Obese and Over 10 years … : AST, ALT, Glucose, AND Lipids ordered within the past 2 years Overweight and Over 10 years OR Obese … : Lipids ordered within the past 2 years Figure 1.
  7. cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
    January 01, 2017 - · One organization has added 75 years of age as a threshold. … processing efficiency · Lookback period for Population 3 · It is reasonable to translate ‘LDL result <= 2 years … starts before end of Measurement Period’ in to a lookback period of 3 years. · Feasibility concerns … processing time to support a longer lookback, work group members voiced consent to keeping the lookback at 3 years … (as opposed to 6 years for an earlier artifact)
  8. cds.ahrq.gov/sites/default/files/cds/artifact/106/Poster_AAPNCE_10.26.15.pptx
    October 13, 2015 - with co-morbidities 62 (56%) Initial Age of Obesity Care Age Diagnosis Testing Referral < 2 years … 31 (29%) 7 (7%) 10 (9%) 2-5 years 69 (65%) 50 (46%) 57 (53%) 6-9 years 3 (3%) 29 (27%) 21 (20%) > … 10 years 0 (0%) 17 (15%) 8 (8%) At what age do clinicians diagnose, evaluate and refer obesity?
  9. cds.ahrq.gov/sites/default/files/workgroups/184656/CDS_Connect_WG_June_2022_Summary.pdf
    January 01, 2022 - None MEETING SUMMARY Presenters reviewed the project’s accomplishments over the last six years … Lacy Fabian (MITRE) began the session recognizing that CDS Connect has been in development for six years … Over the past two years, the CDS Connect team supported FHIR R4- based clinical quality language (CQL … his engagement as an activist for partnerships among patients and caregivers during the last five years … Several WG members shared their support and appreciation of CDS Connect’s progress over the past six years
  10. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - Individuals ≥ 21 years with clinical ASCVD. 2. … Individuals ≥ 21 years who have ever had a fasting or direct laboratory result of LDL ≥190 mg/dL, or … Individuals 40 to 75 years of age with type 1 or types 2 diabetes, and with a value of 70 – 189 mg/dL … for the highest LDL test done in the measurement year or the 2 prior years, and who are not in the … If they are 76 years old, then they fall outside the highest ACC/AHA recommendation).
  11. cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Slides.pdf
    May 01, 2020 - No specific review and update approach − By the end of this project year (9/20) – 16% with date >2 years … − By 9/21 – All will have a date >2 years • 21% of AHRQ stewarded artifacts in the repository ► … − NGC required evidence updates every five years − Quality measures are reviewed annually with full updates … every three years − AHRQ/MITRE CDS Artifacts reviewed annually − Up to date medical textbooks updated … − Review and update, as needed, annually, every two years, other?
  12. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … , and are willing to take low-dose aspirin daily for at least 10 years. … are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … The ACC/AHA recommends assessment of ASCVD risk every 4-6 years. … Results older than 6 years may not reflect the patient's current condition as accurately.
  13. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - Individuals ≥ 21 years with clinical ASCVD. 1. … Individuals 40 to 75 years of age with Type 1 or Types 2 diabetes, and with a value of 70-189 mg/dL for … Criterion: >=21 years old with ASCVD Pop 2 Recommendation male 40 190 TRUE FALSE … If 76 years old, they fall outside the highest ACC/AHA recommendation). … period" Translated as the 'last 3 years' for CDS purposes, corresponding to those 2 years prior and
  14. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS%20for%20Repository.pdf
    May 24, 2023 - Tool – include the total score only Historical treatments – Opioid medications – over the past 2 years … – Non-opioid medications – over the past 2 years – Non-pharmacologic treatments – over the past 2 years … include: PT, acupuncture, electrotherapy, self- management Pulls assessments completed over the past 2 years … drug screen results – all within the past 1 year § Benzodiazepine medications – all within the past 2 years … suicide attempt, sleep-disordered breathing, renal dysfunction, hepatic dysfunction, pregnancy, >=65 years
  15. cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - for timing of and availability of LCL-c results: · The WG members agreed on a lookback period of 6 years … LDL-c laboratory result, citing the 2013 ACC/AHA guideline recommendation to assess risk every 4 to 6 years … may be data availability and/or query response issues when considering lookback periods longer than 6 years … Considerations for timing of available BP measurements: · The WG members agreed on a lookback period of 6 years … for the BP measurements, citing the 2013 ACC/AHA guideline recommendation to assess risk every 4 to 6 years
  16. cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG_v2.pdf
    June 16, 2020 - Excessive alcohol use also includes any drinking by pregnant women or those under 21 years of age (U.S … and all women] or 5 or more drinks a day [for men 65 years and under]”) (National Institute on Drug … Adults are individuals 18 years and older. … This artifact prompts alcohol screening of individuals 18 years and older who do not have active AUD … Adults are individuals 18 years old and older.
  17. cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG%20V3.pdf
    June 16, 2020 - Excessive alcohol use also includes any drinking by pregnant women or those under 21 years of age (U.S … and all women] or 5 or more drinks a day [for men 65 years and under]”) (National Institute on Drug … Adults are individuals 18 years and older. … This artifact prompts alcohol screening of individuals 18 years and older who do not have active AUD … Adults are individuals 18 years old and older.
  18. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
    September 21, 2018 - Tool – include the total score only Historical treatments – Opioid medications – over the past 2 years … – Non-opioid medications – over the past 2 years – Non-pharmacologic treatments – over the past 2 … years – Stool softeners and laxatives – over the past 6 months 10 Medications: Pulls med orders and … PT, acupuncture, electrotherapy, self- management Pulls assessments completed over the past 2 years … drug screen results – all within the past 1 year ▪ Benzodiazepine medications – all within the past 2 years
  19. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    September 21, 2018 - Tool – include the total score only Historical treatments – Opioid medications – over the past 2 years … – Non-opioid medications – over the past 2 years – Non-pharmacologic treatments – over the past 2 … years – Stool softeners and laxatives – over the past 6 months 10 Medications: Pulls med orders and … PT, acupuncture, electrotherapy, self- management Pulls assessments completed over the past 2 years … drug screen results – all within the past 1 year ▪ Benzodiazepine medications – all within the past 2 years
  20. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - Linda is 55 years old and has hypertension and diabetes, which are poorly controlled despite taking … John is 52 years old with low high-density lipoprotein cholesterol (HDL-C) and high LDL-C levels (as … His risk estimate for developing heart disease or stroke in the next 10 years is 15 percent. … Inclusions: Individuals 40 to 75 years old with one or more risk factor for CVD (i.e., hypertension, … Inclusions “within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: